Sangamo Therapeutics Inc
NASDAQ:SGMO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
US |
|
S
|
ShaMaran Petroleum Corp
SWB:3B8
|
CA |
|
Caltagirone Editore SpA
MIL:CED
|
IT |
|
Lottery.com Inc
NASDAQ:LTRY
|
US |
|
Harmonic Inc
NASDAQ:HLIT
|
US |
|
Alerion Clean Power SpA
MIL:ARN
|
IT |
|
Bank UralSib PAO
MOEX:USBN
|
RU |
|
Clinigen Group PLC
LSE:CLIN
|
UK |
|
Vodacom Group Ltd
F:5VD
|
ZA |
|
Yamaguchi Financial Group Inc
TSE:8418
|
JP |
|
I
|
Istyle Inc
F:IY5
|
JP |
|
N
|
ND Rubber PCL
SET:NDR
|
TH |
|
L
|
Lease IT PCL
SET:LIT
|
TH |
|
Crossfirst Bankshares Inc
NASDAQ:CFB
|
US |
|
China High Speed Transmission Equipment Group Co Ltd
OTC:CHSTF
|
HK |
|
E
|
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
|
DE |
|
M
|
Madison Pacific Properties Inc
TSX:MPC
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SGMO's stock price target?
Not Available
SGMO does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sangamo Therapeutics Inc?
Projected CAGR
90%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 90%.